Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Man (FIM) Study of the LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

NCT07385599 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT07385599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Man (FIM) Study of the LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
January 19, 2026
Completion date
March 1, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation (nvaf)